O'Shares Investment Advisers, LLC Abb Vie Inc. Transaction History

O'Shares Investment Advisers, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$137.62 - $174.96 $7.34 Million - $9.33 Million	-53,323 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $393,564 - $488,302	2,982 Added 5.92%	53,323 $8.64 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $393,408 - $497,775	3,662 Added 7.85%	50,341 $6.82 Million
Q3 2021 Nov 05, 2021	SELL	$106.4 - $120.78 $107,038 - $121,504	-1,006 Reduced 2.11%	46,679 $5.04 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $122,043 - $135,963	1,160 Added 2.49%	47,685 $5.37 Million
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $19,334 - $21,285	-189 Reduced 0.4%	46,525 $5.04 Million
Q4 2020 Feb 01, 2021	BUY	$80.49 - $108.67 $357,697 - $482,929	4,444 Added 10.51%	46,714 $5.01 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $3.63 Million - $4.26 Million	42,270 New	42,270 $3.7 Million
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $6.15 Million - $8.23 Million	-83,819 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $4,192 - $6,356	-65 Reduced 0.08%	83,819 $6.39 Million
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $393,397 - $492,223	5,454 Added 6.95%	83,884 $7.43 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $1.53 Million - $1.84 Million	24,236 Added 44.72%	78,430 $5.94 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $207,743 - $265,544	3,162 Added 6.2%	54,194 $3.94 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $99,510 - $117,119	1,290 Added 2.59%	51,032 $4.11 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $3.87 Million - $4.78 Million	49,742 New	49,742 $4.59 Million

3,697

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $345B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of O'Shares Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shares Investment Advisers, LLC with notifications on news.